Pricing and reimbursement
AIFA intervenes in the governance of pharmaceutical expenditure by negotiating the price of medicinal products and managing the National Pharmaceutical Formulary (PFN).
In addition, AIFA monitors the appropriateness of use of medicines through the development, management and analysis of registers and consumption data.
It periodically reviews the Notes, which are regulatory tools that define the eligibility for reimbursement of some medicinal products and are updated on the basis of new scientific evidence and the needs of daily medical practice on the national territory.
Every month, the Agency also publishes the updated transparency lists, which are the lists of medicinal products whose patent coverage has expired, with the relative reference prices.
15/04/2020
10/04/2020
09/04/2020
09/04/2020
06/04/2020
20/03/2020
25/02/2020
24/02/2020
21/02/2020
12/02/2020
07/02/2020
31/01/2020
18/12/2019
18/12/2019
12/12/2019
12/12/2019
11/12/2019
04/12/2019
04/12/2019
02/12/2019
25/11/2019
20/11/2019
11/11/2019
31/10/2019
29/10/2019
27/10/2019
04/04/2019
18/10/2019
17/10/2019
18/02/2013
14/10/2019
11/10/2019
23/09/2019
27/12/2018
18/12/2018
07/12/2018